<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70767</article-id><article-id pub-id-type="doi">10.7554/eLife.70767</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Inference of the SARS-CoV-2 generation time using UK household data</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-217665"><name><surname>Hart</surname><given-names>William Stephen</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2504-6860</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189538"><name><surname>Abbott</surname><given-names>Sam</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-130339"><name><surname>Endo</surname><given-names>Akira</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6377-7296</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-187386"><name><surname>Hellewell</surname><given-names>Joel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256284"><name><surname>Miller</surname><given-names>Elizabeth</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1884-0097</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58530"><name><surname>Andrews</surname><given-names>Nick</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-173765"><name><surname>Maini</surname><given-names>Philip K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0146-9164</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18737"><name><surname>Funk</surname><given-names>Sebastian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2842-3406</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222913"><name><surname>Thompson</surname><given-names>Robin N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8545-5212</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Mathematical Institute</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Centre for the Mathematical Modelling of Infectious Diseases</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Infectious Disease Epidemiology</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Data and Analytical Sciences, UK Health Security Agency</institution>, <institution>Public Health England</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Mathematics Institute</institution>, <institution>University of Warwick</institution>, <addr-line><named-content content-type="city">Coventry</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-195903"><name><surname>Flegg</surname><given-names>Jennifer</given-names></name><role>Reviewing editor</role><aff><institution>The University of Melbourne</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>william.hart@keble.ox.ac.uk</email> (WH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>02</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e70767</elocation-id><history><date date-type="received"><day>29</day><month>05</month><year>2021</year></date><date date-type="accepted"><day>07</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Hart et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hart et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70767-v1.pdf"/><abstract><p>The distribution of the generation time (the interval between individuals becoming infected and transmitting the virus) characterises changes in the transmission risk during SARS-CoV-2 infections. Inferring the generation time distribution is essential to plan and assess public health measures. We previously developed a mechanistic approach for estimating the generation time, which provided an improved fit to data from the early months of the COVID-19 pandemic (December 2019-March 2020) compared to existing models (Hart et al., 2021). However, few estimates of the generation time exist based on data from later in the pandemic. Here, using data from a household study conducted from March-November 2020 in the UK, we provide updated estimates of the generation time. We considered both a commonly used approach in which the transmission risk is assumed to be independent of when symptoms develop, and our mechanistic model in which transmission and symptoms are linked explicitly. Assuming independent transmission and symptoms, we estimated a mean generation time (4.2 days, 95% credible interval 3.3-5.3 days) similar to previous estimates from other countries, but with a higher standard deviation (4.9 days, 3.0-8.3 days). Using our mechanistic approach, we estimated a longer mean generation time (5.9 days, 5.2-7.0 days) and a similar standard deviation (4.8 days, 4.0-6.3 days). As well as estimating the generation time using data from the entire study period, we also considered whether the generation time varied temporally. Both models suggest a shorter mean generation time in September-November 2020 compared to earlier months. Since the SARS-CoV-2 generation time appears to be changing, further data collection and analysis is necessary to continue to monitor ongoing transmission and inform future public health policy decisions.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000266</institution-id><institution>Engineering and Physical Sciences Research Council</institution></institution-wrap></funding-source><award-id>Excellence Award,EP/R513295/1</award-id><principal-award-recipient><name><surname>Hart</surname><given-names>William Stephen</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><award-id>NIHR200929</award-id><principal-award-recipient><name><surname>Miller</surname><given-names>Elizabeth</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Taisho Pharmaceutical Co., Ltd</institution></institution-wrap></funding-source><award-id>Research grant</award-id><principal-award-recipient><name><surname>Endo</surname><given-names>Akira</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>UKRI</institution></institution-wrap></funding-source><award-id>EP/V053507/1</award-id><principal-award-recipient><name><surname>Thompson</surname><given-names>Robin N</given-names></name></principal-award-recipient></award-group><funding-statement>The authors had sole responsibility for the study design, data collection, data analysis, data interpretation, and writing of the report.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Akira Endo, received a research grant from Taisho Pharmaceutical Co., Ltd..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and its supporting files; a Source Data file has been provided for Figure 1. Code for reproducing our results is available at https://github.com/will-s-hart/UK-generation-times.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hart WS</collab></person-group><year iso-8601-date="2021">2021</year><source>UK-generation-times</source><ext-link ext-link-type="uri" xlink:href="https://github.com/will-s-hart/UK-generation-times">https://github.com/will-s-hart/UK-generation-times</ext-link><comment>GitHub</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-70767-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>